175 related articles for article (PubMed ID: 37043085)
1. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy.
Xu Z; Huang J; Zhang T; Xu W; Liao X; Wang Y; Wang G
J Mater Sci Mater Med; 2023 Apr; 34(4):18. PubMed ID: 37043085
[TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling.
Chen S; Ren Y; Duan P
Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984
[TBL] [Abstract][Full Text] [Related]
5. A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy.
Yang MY; Tu YF; Feng KK; Yin MD; Fang YF; Le JQ; Luo BY; Tan XR; Shao JW
Colloids Surf B Biointerfaces; 2023 Sep; 229():113468. PubMed ID: 37515961
[TBL] [Abstract][Full Text] [Related]
6. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
7. Dual drive mode polydopamine nanomotors for continuous treatment of an inferior vena cava thrombus.
Fang D; Li T; Wu Z; Wang Q; Wan M; Zhou M; Mao C
J Mater Chem B; 2021 Oct; 9(41):8659-8666. PubMed ID: 34608926
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis.
Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y
Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186
[TBL] [Abstract][Full Text] [Related]
9. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
10. Novel biomimetic dual-mode nanodroplets as ultrasound contrast agents with potential ability of precise detection and photothermal ablation of tumors.
Liang Y; Yang H; Li Q; Zhao P; Li H; Zhang Y; Cai W; Ma X; Duan Y
Cancer Chemother Pharmacol; 2020 Sep; 86(3):405-418. PubMed ID: 32797251
[TBL] [Abstract][Full Text] [Related]
11. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X
Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy.
Xie X; Wang H; Williams GR; Yang Y; Zheng Y; Wu J; Zhu LM
Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31450749
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis based on magnetically-controlled surface-functionalized Fe
Chang M; Lin YH; Gabayno JL; Li Q; Liu X
Bioengineered; 2017 Jan; 8(1):29-35. PubMed ID: 27689864
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
15. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic Antidote Nanoparticles: a Novel Strategy for Chronic Heavy Metal Poisoning.
Wang H; Yao Q; Zhu W; Yang Y; Gao C; Han C; Chu X
AAPS PharmSciTech; 2022 Nov; 24(1):12. PubMed ID: 36451071
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Properties of Thrombus-Targeted Urokinase/Multi-Walled Carbon Nanotubes (MWCNTs)-Chitosan (CS)-RGD Drug Delivery System.
Zhang R; Luo S; Hao LK; Jiang YY; Gao Y; Zhang NN; Zhang XC; Song YM
J Biomed Nanotechnol; 2021 Sep; 17(9):1711-1725. PubMed ID: 34688316
[TBL] [Abstract][Full Text] [Related]
18. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X
Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328
[TBL] [Abstract][Full Text] [Related]
19. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
20. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
